Chris Parker KC

Practice Areas

Dispute Resolution

International Arbitration

Commercial Arbitration

Global Advocacy

Commercial Litigation

Career

Chris has acted as counsel and advocate in ad hoc and institutional arbitrations in a number of jurisdictions and under various governing laws. He has broad experience of advising on international disputes, particularly in the energy, life sciences and mining sectors. He was appointed as Queen's Counsel (now King's Counsel) in March 2022.

Chris is Co-Head of our Pharmaceuticals sector team.

Personal

Chris is a partner specialising in international arbitration.

Work Highlights

an international pharmaceutical company in securing a favourable award in an ICC arbitration in Singapore with over US$0.5 billion in dispute concerning a co-promotion agreement

a US energy major in arbitration proceedings under the UNCITRAL Arbitration Rules relating to a post M&A dispute concerning an offshore oil field in the North Sea

a biotechnology company in an arbitration relating to one of the leading Covid-19 vaccines

the owner of a LNG terminal in an ICC arbitration concerning a long term gas supply agreement relating to an offshore African field

a global pharmaceuticals company in a significant victory in a SIAC arbitration in Singapore arising from licensing and research agreements, with a value in excess of US$ 300 million